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Maternal Smoking in Pregnancy: Do the Effects on Innate
(Toll-Like Receptor) Function Have Implications for
Subsequent Allergic Disease?
Susan L. Prescott, MBBS, BMedSci, PhD, FRACP and Paul S. Noakes, BSc(Hons), PhD
Subtle increases in immaturity of immune function in early infancy have been implicated in the rising susceptibility to allergic
disease, particularly relative impairment of type 1 interferon (IFN)-c responses in the neonatal period. Although genetic
predisposition is a clear risk factor, the escalating rates of allergic disease in infancy suggest that environmental factors are also
implicated. We previously showed that maternal smoking in pregnancy may impair neonatal IFN-c responses. Our more recent
studies now indicate that this common avoidable toxic exposure is also associated with attenuation of innate immune function, with
attenuated Toll-like receptor (TLR)-mediated microbial responses (including TLR-2, -3, -4, and -9 responses). Most notably, the effects
were more marked if the mothers were also allergic. In this review, we discuss the significance of these observations in the context of
the emerging hypothesis that variations in TLR function in early life may be implicated in allergic propensity. There is now growing
evidence that many of the key pathways involved in subsequent T-cell programming and regulation (namely, antigen-presenting
cells and regulatory T cells) rely heavily on microbe-driven TLR activation for maturation and function. Factors that influence the
function and activity of these innate pathways in early life may contribute to the increasing predisposition for allergic disease.
Although ‘‘cleaner’’ environments have been implicated, here we explore the possibility that other common environmental
exposures (such as maternal smoking) could also play a role.
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A
striking increase in immune-mediated diseases has
been one of the most concerning changes in disease
prevalence during the late twentieth century. Although the
reasons for this are not clear, environmental changes are
clearly implicated. This change has involved major
increases in apparently diverse disease processes, including
a spectrum of allergic diseases and autoimmune diseases.
1
This increase in immune dysregulation, often very early in
life, has led to intense interest in factors that influence to
early immune maturation.
Although microbial factors are known to enhance
immune maturation, factors that may inhibit early
immune maturation are less well documented. Here we
explore the potential role of maternal smoking in
pregnancy on infant immune development. Specifically,
we examine the novel hypothesis that maternal smoking
causes a relative impairment of innate defense through
effects on the developing immune system in pregnancy.
We speculate that these effects may not only contribute to
the increased risk of infection
2 but may also be implicated
in the increased rates of other forms of chronic
inflammatory respiratory disease seen in these children,
3
including asthma and recurrent wheezing.
4,5 Whereas
there have been extensive studies of the effects of cigarette
smoking on neonatal lung mechanics,
6,7 there is only
relatively limited information about the effects on devel-
oping immune responses.
The prevalence of smoking in women of child-bearing
age generally ranges between 17 and 35% around the
world. Although the rates of smoking in pregnancy have
generally declined over the last 10 years, a significant
proportion (10–20%) of women continue to smoke in
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ethnicity, education, and socioeconomic level.
8–11
At this stage, it is unclear if the decline in maternal
smoking is linked to the declining rates of asthma in some
developed countries during the same period.
12 Although it is
unlikely that maternal smoking is the primary causal factor
in the changing prevalence of asthma, we are proposing that
it is an important contributing factor, with significant
potential to interact with other genetic factors and environ-
mental risk factors to modify disease propensity.
Preliminary Evidence that Maternal Smoking Has
Immunologic Effects on the Developing Fetus
There has been growing evidence that subtle increases in
immaturity of immune function, particularly Th1 interferon
(IFN)-c responses, during early infancy may be associated
with allergy risk and subsequent disease.
13–16 We previously
noted that maternal smoking in pregnancy is associated with
lower Th1 responses to polyclonal stimulation,
17 although
this study measured messenger ribonucleic acid (mRNA)
expression rather than protein levels. Others have also noted
differences in the immune function of neonates whose
mothers smoked in pregnancy. Early studies noted that
parental smoking is associated with higher cord blood
immunoglobulin E (IgE) levels,
18 and, subsequently,
Devereux and colleagues observed that maternal smoking
is associated with stronger neonatal allergen-specific
responses,
19 providing preliminary evidence that maternal
smokinghaseffectsonfetalcellularimmunefunction.Inour
more recent studies, we measured the specific effects of
smoking on Toll-like receptor (TLR) innate defence path-
ways (below), which could both explain an increased
susceptibility to infection and have implications for
subsequent allergen-specific immune development.
Role of Innate Immunity in Subsequent Immune
Development
Innate immunity plays a key role in immune defence in the
neonatal period before the development of environmen-
tally driven adaptive immune responses. This aspect of the
immune system is activated through highly conserved
receptors, including the TLR family, that recognize a broad
range of microbial agents.
20 These receptors are found on
many cells involved in immediate host defence, such as
neutrophils, natural killer cells, and antigen-presenting
cells (APCs). Differential expression of TLR on these cell
types (as summarized in Figure 1) allows specialized
responses to different microbial components. Activation of
APCs through the TLR also has implications for adaptive
immune function as these cells play a critical role in
programming effector responses. Once activated via these
pathways, dendritic cells (DCs) and other APCs show
Figure 1. Cell surface expression of
Toll-like receptors and their ligands.
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cytokines (including interleukin [IL]-12), which favour
Th1 immune differentiation. TLRs (TLR-4, -5, -7, and -8)
have also more recently been identified on CD4
+CD25
+ T
regulatory cells
21 that play a critical role in controlling
immune responses.
22 Thus, it has been proposed that TLR-
mediated activation of both APCs and regulatory T cells
may play an important role in reducing the risk of Th2-
mediated allergic responses.
22,23 This is obviously of most
relevance in early life when programming of immunologic
function is initiated.
We speculate that TLR function matures in the
postnatal period and that children who develop allergic
disease have differences in these development patterns as a
result of genetic predisposition and/or environmental
influences. This hypothesis is based on preliminary
evidence that TLR function is developmentally regulated,
with differences between infants and adults,
24,25 and that
genetic and environmental factors can modify TLR
function in early life, as discussed below.
Emerging Interest in the Role of Early TLR Function
in the Risk of Allergic Disease
At this stage, there is only preliminary evidence that
children at high risk of allergic disease have altered TLR
function. First, in a small study, newborns of allergic
women (N 5 9) had significantly lower in vitro responses
after TLR-2 ligation (with peptidoglycan) compared with
those of nonallergic women (p 5 .03).
26 In another larger
study (N 5 185), maternal allergy was associated with
significantly lower levels of TLR-2, TLR-4, and CD14
mRNA in cord blood samples.
27 Neonates at ‘‘high risk’’
of allergy have also been noted to have altered genera-
tion of putative T regulatory cell populations after
lipopolysaccharide (LPS) stimulation, presumably through
TLR-4 pathways.
28 At this stage, the significance of these
findings is unclear. Maternal allergy appears to confer
‘‘allergy risk’’ not only by genetic inheritance but also by
direct immune interactions in pregnancy, as we recently
reported.
29
Evidence that Environmental Factors that Modify
Early TLR-Mediated Immune Activation Can Alter
Allergy Risk
There is good evidence in animal models that TLR
activation using microbial products can modify immune
development and the risk of allergic sensitization, although
this has not been examined directly in humans. Blumer
and colleaguers recently demonstrated that TLR-4 activa-
tion (giving endotoxin) in pregnancy enhanced neonatal
Th1 IFN-c responses and inhibited (ovalbumin) allergen
sensitization in the offspring.
30 Tulic and colleagues
showed similar effects of the same TLR-4 ligand in the
postnatal period, but, notably, the inhibition of allergic
responses was seen only when endotoxin was given before
responses were established.
31 In humans, exposure to
farming animals (and presumably higher endotoxin levels)
has been associated with both increased gene expression
(of TLR-2: odds ratio 1.16, 95% confidence interval [CI]
1.07–1.26; of TLR-4: odds ratio 1.12, 95% CI 1.04–1.2) and
the risk of allergic sensitization (adjusted odds ratio 0.58,
95% CI 0.39–0.86).
32 Intervention studies also suggest that
administration of bacterial products to children may have
clinical
33,34 and immune
35 effects. Although it has been
inferred that these variations in microbial exposure may be
responsible for differences in innate (and subsequent
cognate) immune function, this has not been documented
directly.
There is also evidence that genetically conferred
variations in TLR function may be implicated in allergic
disease. TLR-2 genetic polymorphisms were shown to have
a protective effect on asthma.
36 Notably, the ‘‘protective’’
e f f e c tw a ss e e no n l yw h e nc h i l d r e nw e r er a i s e di n
environments with ‘‘high’’ microbial burden, illustrating
the interactive effects of genetic and environmental factors
on these pathways. Polymorphisms in the TLR4 gene have
been associated with atopic asthma in some
37 but not all
studies,
38,39 raising questions over the functional signifi-
cance of these polymorphisms. These conflicting results
could also suggest complex gene and environment
interactions and that the same genetic background might
result in the expression of different phenotypes in different
environments. This requires large-scale population studies
involving many thousands of children, which are becom-
ing more realistic as multicentre collaborations develop
further in this field.
Together, these findings suggest that alterations in TLR
function, either as a result of differences in early environ-
mentalexposuresorfunctionalgeneticpolymorphisms,have
an effect on subsequent development of adaptive immune
function.Hereweexploretheeffectsofmaternalsmokingon
TLR function and these interactions.
Effects of Maternal Smoking in Innate (TLR)
Immune Development
The increased rate of respiratory disease
40 and infection
2 in
infants of smoking mothers is well recognized. These
12 Allergy, Asthma, and Clinical Immunology, Volume 3, Number 1, 2007effects may be mediated by a number of pathways,
including in utero effects and ongoing toxic effects in the
postnatal period. Adverse effects on airway development
are well documented,
41–45 and there is also preliminary
evidence that maternal smoking may also have effects on
immune development.
17,19 We now speculate that the
toxic effects of maternal smoking may be having effects on
the development and function of innate responses, and
this may be implicated in the susceptibility to both
infection and asthma in exposed infants.
We recently addressed this hypothesis in a prospective
cohort study that compared innate immune function in the
neonatesof women whosmokedinpregnancy (n5 58)with
that of the neonates of nonsmokers (n 5 59). Women were
recruited early in pregnancy when detailed clinical and
smoking histories were collected. Cotinine levels were
measured in maternal and cord blood plasma to confirm
differences in cigarette smoke exposure. This demonstrated
significantly higher levels in the smoking group (p , .001),
with largely undetectable levels in the nonsmokers, and
significant correlations between cotinine levels and self-
reported smoke exposure. Cord blood mononuclear cells
were isolated to assess the effects of maternal smoking in
pregnancy on TLR function, using optimal doses of specific
microbial ligands for TLR-2 ligand (pansorbin
[Staphylococcus aureus] 0.1%), TLR-3 ligand (polyinosinic-
polycytidylic acid:cytosine-phosphate-guanine [CpG] 30 mg/
mL), TLR-4 ligand (LPS 10 ng/mL), and TLR-9 ligand (CpG
1.66 mg/mL). Functional responses to these ligands were
assessed by cytokine production (tumor necrosis factor
[TNF]-a,I L - 1 0 ,a n dI L - 6 ,p r i n c i p a l l yd e r i v e df r o mA P C si n
this culture system) after 48 hours, as previously described.
46
We observed that the infants of smoking mothers showed
significantattenuationofanumberofaspectsofinnateTLR-
mediated responses compared with the infants of non-
smokers.
47 This included significantly lower cytokine
responses following TLR-2 (TNF-a, p 5 .004; IL-6, p 5
.045; IL-10, p 5 .014), TLR-3 (TNF-a, p 5 .044), TLR-4
(TNF-a, p 5 .034), and TLR-9 (IL-6, p 5 .046) activation.
There were also consistent negative correlations between
cotinine levels and cytokine (IL-6, IL-10, and TNF-a)
responses to these TLRs. Although women who smoked
were also more likely to have lower educational levels and
consume other recreational drugs during pregnancy, the
relationships between maternal smoking status and immune
function remained evident after these effects were accounted
for in multiple regression modeling. These observations
appear to confirm our hypothesis that maternal smoking
may attenuate aspects of innate immune function in the
neonatal period; however, it remains possible that other
maternal factors that could not be measured could
contribute the differences between these populations.
Possible Pathways of Influence: Immune Effects of
Oxidative Stress?
Cigarette smoke is a major source of free radicals and
oxidative stress.
48 Recent studies have identified smoking-
induced disruption of oxygen-related responses that are
known to play a key role in placental cytotrophoblast
proliferation and differentiation during critical early stages
of development.
49 Most notably, effects were also seen
when women were passively exposed to tobacco smoke.
49
Foreseeably, these disruptions in antioxidant systems could
lead to further disruptions of local immune function in the
placenta and in the fetus. Oxidative stress plays a major
role in inflammation. Macrophages infiltrate inflamed
tissue and release reactive oxygen species and reactive
nitrogen species and, in doing so, become depleted of
antioxidants, as reflected by their reduced glutathione
status.
50 It has been demonstrated that a change in the
‘‘redox’’ status (reduced glutathione) of APCs (macro-
phages) promotes CD4 T-cell Th2 differentiation
50 and the
production of IL-4 and IL-5, which contribute allergic
inflammation. Specifically, oxidative stress promotes pro-
Th2 signaling by APCs by reducing IL-12 production in
mice
50 and humans (which can be reversed by antiox-
idants
51). Thus, the effects of modifying oxidative function
provide a plausible pathway for smoking in modifying
developing immune responses.
Molecular Targets: Effects on Transcription Factors?
The production of inflammatory cytokines is mediated
through transcription factors such as nuclear factor (NF)-
kB and activator protein 1.
52,53 In vitro studies demon-
strate that cigarette smoke extracts reduce proinflamma-
tory LPS-induced TLR-4 signaling by inhibiting
transcription factors.
54,55 More recently, Valacchi and
colleagues demonstrated that a major constituent of
cigarette smoke (acrolein) suppresses epithelial production
of inflammatory chemokine IL-8 through direct inhibition
of NF-kB.
56 Based on these findings, we speculate that
smoking may affect TLR signaling via nuclear effects on
transcription factors (Figure 2). There may be preliminary
evidence that this occurs following direct mucosal
exposure,
54,56 and it is possible that the systemic in utero
effects observed in our study could be mediated through a
similar pathway. This could be assessed in future studies
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mRNA expression following TLR ligation.
Differential Effects of Maternal Smoking in Infants
at High Risk of Allergy?
Our study (above) included approximately an equal
number of allergic (n 5 62) and nonallergic women (n
5 60), who were distributed equally among the smoking
group (n 5 32 allergic) and the nonsmokers (n 5 30
allergic). Allergic status was confirmed by allergen
skinprick testing (SPT) to common allergens (with at
least one positive SPT to dust mite, cats, dogs, grass
pollens, moulds, or cockroaches).
First, we examined the effects of maternal allergy on
TLR-mediated responses (as the proportion of smokers in
Figure 2. Potential mechanisms of action: possible effects of smoking in common transduction pathways. Reproduced with permission from Hole
J. The innate immune mechanisms of prostate epithelium during bacterial infection [thesis]. Perth: Department of Microbiology, University of
Western Australia; 2003.
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(discussed above) have noted that infants at high risk of
allergic disease (based on maternal allergy) have reduced
TLR expression
27 and function,
26 we did not see any
consistent effects in this study. The only difference that
approached statistical significance was a trend for lower
IL-10 responses following TLR-2 ligation (with pansorbin)
(p 5 .06) in the allergic group (n 5 62).
Second, we determined if infants at high risk of allergy
(maternal allergy) are also more susceptible to the effects
of maternal smoking. Whereas TNF-a responses (to TLR-
2, -3, and -4 activation) were significantly attenuated in
smokers, this was seen only in infants of atopic mothers
(for TLR-2, p 5 .014; TLR-3, p 5 .048; and TLR-4, p 5
.014), with no significant effects of smoking in the
nonatopic group. Although there was a trend in the
nonatopic group for smokers to have impaired TNF-a
responses to TLR-2, this did not reach statistical
significance (p 5 .094). These findings indicate that the
effects of smoking on TNF-a responses are significantly
enhanced by maternal allergy. Thus, both maternal
allergy
27 and function
26 and maternal smoking
47 may
have effects on aspects of neonatal immune function
(although in our study, smoking had a more significant
effects). Although some of these effects are independent,
our data also suggest some interactive potentiating effects.
Specifically, we have shown that maternal atopic status
selectively amplifies the effect of smoking on some
activation pathways.
Implications of Our Findings for the Risk of
Subsequent Development of Allergic Disease?
Whereas maternal smoking in pregnancy has been
associated with an increased risk of asthma and reduced
lung function is well described,
4,5 the relationship between
subsequent atopic risk has been more controversial. A
number of studies have linked parental smoking with
markers of atopy in children,
57,58 including serum IgE
levels,
7,59–62 eosinophilia,
7,63 and positive SPTs.
64 Despite
this, a systematic review by Strachan and Cook in 1998 did
not find any conclusive association.
65 However, this did
not include the results of a more recent study by Kulig and
colleagues, which reported a significantly higher risk of
sensitization to food allergens (odds ratio 2.3, 95% CI 1.1–
4.6) in children exposed to maternal smoking compared
with unexposed children.
66 It is now well recognized that
genetic polymorphisms in antioxidant pathways may
contribute to differences in susceptibility to the effects of
cigarette smoke,
67 and genetic differences could account
for some of the differences between studies.
Our recent findings could provide an important
pathway through which maternal smoking could potenti-
ate the development of allergy. We have shown that
smoking has direct effects on neonatal APC function, as
detected by impaired innate responses to microbial
stimulation. It could be argued that persistent immaturity
of APC responses to bacteria could interfere with microbe-
driven Th1 maturation (which is mediated via TLR
pathways). Other studies have shown an in vitro
immunosuppressive effect of nicotine on APC (DC)
function, including as antigen-capturing, cytokine produc-
tion (particularly IL-12 production), and eventually T-cell
priming and polarization.
68 This has implications for
allergic risk as impaired Th1 function in the perinatal
period has been linked to allergic risk in many studies.
13–16
TLR activation is also important for activation of T
regulatory cells, which are also important for suppression
of allergic Th2 responses. Together, these effects could
contribute to increased allergic risk.
However, at this stage, it is not clear how long these
effects on APC function might persist in the postnatal
period. It could also be argued that a resultant increased
susceptibility to infection could provide a strong source of
APC-driven Th1 immune maturation. Thus, although it is
possible that the effects of maternal smoking on early TLR
function may contribute to the well-documented increase
in early postnatal susceptibility to respiratory tract
infections in exposure infants,
2 further studies are needed
to examine the longitudinal effects on the development of
allergen-specific memory.
Concluding Comments
In summary, our findings show that in addition to the
effects on developing airways, maternal smoking in
pregnancy also has significant immunologic effects that
could contribute to increased risk of respiratory infections
and asthma. These effects appear to be mediated through
effects on TLR-mediated innate response pathways, which
also promote regulatory pathways in the inhibition of
allergic immune responses. This highlights the fact that
other environmental interactions are highly relevant to the
‘‘hygiene hypothesis.’’ Specifically, although the level of
early microbial exposure is the strongest determinant of
TLR-mediated immune maturation, our findings demon-
strate that other environmental exposures (such as
maternal smoking) may also have an influence. There is
no doubt that smoking should be avoided in all
Prescott and Noakes, Implications of Maternal Smoking for Subsequent Allergic Disease 15pregnancies because of the many adverse effects, and our
studies suggest that the adverse effects on fetal immune
development could be even greater in atopic women.
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